San Diego Biotechnology Network

Artificial intelligence is already making its way into healthcare and allowing for improvements patient care. The possibilities go way beyond what you may have imagined. In this episode, Dr Eric Topol, Executive Vice President at Scripps Research and the founder and director of Scripps Research Translational Institute, describes what some of those advances might look like for both the doctor and the patient. He thinks there is potential for automated note taking, for example, to give back the gift of time spent with each patient in office visits, something that has decreased significantly since he was in med school.

He is likewise concerned that the savings might be used otherwise (more “productivity”) which would further erode the doctor-patient relationship. Face to face time is important for better outcomes. Listen to this episode to find out what relative value units are and why this may be the last chance for doctors to influence the direction of their profession. Dr Topol is the author of Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again.

San Diego Biotechnology Network

Robin Toft is the Chairman and Founder of The Toft Group, an executive search firm and author of the book: We Can: The Executive Woman’s Guide to Career Advancement. In this episode she shares three things you must have to advance your career Confidence, Competence and Connections) and how to develop/deploy them. This episode is packed with good advice. Here are some highlights. You are the CEO of you. You should spend 75% of your time creating excellent value for your company. The other 25% should be spent planning how you can add more. Every CEO is thinking ahead and you should to. Companies value people who can think ahead strategically.


Artificial Intelligence in Precision Medicine: State of the Art at Stanford

Matthew Lungren, MD, MPH, Associate Director, Stanford Center for Artificial Intelligence in Medicine and Imaging, Stanford Child Health Research Institute; Faculty Scholar; Assistant Professor of Radiology, Radiology, Stanford University, School of Medicine, Lucile Packard Children’s Hospital

Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years.


Gene Therapy for Rare Disorders

Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field.



Putting the AI in Wait: Is It Ready to Solve All Our Pathology Problems?

Richard M. Levenson, MD, Professor and Vice Chair for Strategic Technologies, Department of Pathology & Laboratory Medicine, UC Davis Medical Center

Dr. Richard Levenson discusses the role of AI in digital pathology – what works, and what needs to be done for AI to reach its full potential.

Real precision medicine is starting with the patient: Harness patient biology and AI to enable biomarker-driven personalized medicine

Invited guest: Niven R. Narain, PhD, Co-Founder, President & CEO, BERG
Invited Interviewer: Harry Glorikian, General Partner, New Ventures Funds

Harry Glorikian interviews Niven R. Narain about his approach on how to add more precision to the process of drug development and diagnostic development while engage more reproducibility. Niven also discusses how to use the biomarkers not only as a readout but as a vehicle and an agent to design clinical trials much differently.

Mark Stewart and Friends of Cancer Research Target the Tumor Mutational Burden and Pursue Harmonization

Mark Stewart, PhD, Vice President, Science Policy, Friends of Cancer Research, Seracare

Dr. Mark Stewart discusses the role of the tumor mutational burden (TMB) in cancer research and the need for harmonization throughout the process.

Personalized Estimation of Motality Risk – Digital Age Makes it a Reality

with Bradley A. Perkins, MD, Co-Founder & CEO, Sapiens Data Science, Inc.

Dr. Bradley Perkins develops a digital platform that can estimate personalized ten year mortality risk. In this podcast, he shares with us what this platform is and how it works to protect and improve the health of individuals and families. In the era of personalized medicine, Dr. Perkins explains what the necessary steps to bring this platform to the general public, gives us other personalized medicine examples and how it will affect the cost of medical care.

Topics include Precision medicine, Personalized medicine, Digital platform, Wellness Prediction, Health data


Diagnostic and Clinical Implications of a Targeted NGS panel in Autism Spectrum Disorders

with Yu Jin Park, Specialist, Severance Hospital

Yu Jin Park of Severance Hospital speaks to CHI on March 23, 2017. Mr. Park was a Poster Winner at the Molecular Medicine Tri-conference that ran this past February, 2017.

Topics include using next generation sequencing in a gene panel for Autistic Spectrum Disorder(ASD).

Early Detection of Cancer: Myth or Reality?

with Abhijit Patel, Ph.D., Assistant Professor, Therapeutic Radiology, Yale University, United States

Abhijit Patel of the Yale University School of Medicine recently spoke with CHI, on February 23, 2017 he will be speaking during the Circulating Cell-Free DNA Symposium at Molecular Medicine Tri-Conference. As a physician-scientist, Dr. Patel maintains an active clinical radiation oncology practice. His research group at Yale is working to develop and clinically validate novel noninvasive DNA- and RNA-based cancer diagnostics.

In this podcast, Dr. Patel spoke to CHI to discuss the emerging technologies and challenges in liquid biopsy including developing robust and sensitive assays to detect early stage disease.

For more information, please visit TriConference.com/Circulating-DNA

The Future of Bioinformatics in Personalized & Precision Medicine

with John Mattison, M.D., Assistant Medical Director, Chief Medical Information Officer, Kaiser Permanente, SCAL

John Mattison of Kaiser Permanente speaks to CHI on November, 14, 2016. Dr. Mattison will be chairman at the Bioinformatics track during the Molecular Medicine Triconference, February 19 - 24, in San Francisco, CA.

Topics include discussing the current state of bio-informatics and the large influx of information, as well as how to decide what information is pertinent with regards to which diseases. The talk concludes with his excitement to see how others are progressing along this topic as well.

For more information, please visit TriConference.com/Bioinformatics-Big-Data

Bits to Bedside: Using Big Data to Create Better Precision Medicine

with Dexter Hadley, Assistant Professor of Pediatrics, Institute of Computational Health Sciences, University of California, San Francisco

Dexter Hadley of UCSF speaks to CHI on November, 29, 2016. Dr. Hadley will be speaking during the Bioinformatics track during the Molecular Medicine Triconference, February 19 - 24, in San Francisco, CA.

Topics include developing a learning healthcare system to help make medicine more objective rather than subjective in terms of identifying melanoma and other symptoms, as well as creating an app to bring better personalized medicine to individuals.

For more information, please visit TriConference.com/Bioinformatics-Big-Data/


Next-Generation Sequencing for Detecting Antimicrobial Resistance

with Romney M. Humphries, Ph.D., D(ABMM), Assistant Professor, UCLA Pathology & Laboratory Medicine, Section Chief of Clinical Microbiology, David Geffen School of Medicine, University of California, Los Angeles

Romney Humphries, Assistant Professor, UCLA Pathology & Laboratory Medicine, Section Chief of Clinical Microbiology, David Geffen School of Medicine, University of California, Los Angeles spoke to CHI to discuss how Next-Generation Sequencing has changed the way scientists detect antimicrobial resistance as well as the challenges scienctists face moving forward.

Dr. Humprhies is one of our speakers at the Molecular Diagnostics for Infectious Disease conference, taking place March 7-9 as part of the Molecular Medicine TriConference. For details, visit TriConference.com/Molecular-Diagnostics-for-Infectious-Disease/

Metabolomics for Sepsis: Predictive Biomarkers

with Raymond Langley, Ph.D., Professor, Clinical Genomics, Mitochondrial Diseases, Maastricht University Medical Center

CHI chats with Dr. Raymond J. Langley, Assistant Professor, Department of Pharmacology, University of South Alabama. Dr. Langley discusses the latest research and developments in metabolomics risk analysis models for sepsis and predictive biomarkers for patient survival, as well as the current challenges in developing technology for metabolomics diagnostics for sepsis.

Dr. Langley is one of our speakers at the Molecular Diagnostics for Infectious Disease conference, taking place March 7-9 as part of the . For details, visit www.TriConference.com/Molecular-Diagnostics-for-Infectious-Disease/

Topics Include: Sepsis, Metabolomics, Molecular Diagnostics, Infectious Disease


Point-of-Care Diagnostics in CVS' MinuteClinics

Daniel R. Kerls, MBA, OTR/L, Director, Ambulatory Operations, CVS MinuteClinic
Alexander Sbordone, Operations Manager, CVS MinuteClinic

CHI's Samantha Lewis speaks with Daniel Kerls, director of ambulatory operations at CVS' Minute Clinic, as well as Alexander Sbordone, who is the Minute Clinic operations manager at CVS. Kerls and Sbordone discuss staffing MinuteClinic, the types of diagnostic tests they seek out, and the future direction of rapid clinics.

Topics Include: Point of care diagnostics, rapid clinics, retail health clinics, MinuteClinic and CVS

Inaugural Swimming with the Sharks Competition at Molecular Medicine

Alan B. Carter, Consultant, Sales Performance International

Interview with Moderator of the Inaugural Swimming with the Sharks competition, for start-ups to compete for venture funding in the genomic space.

UPMC’s Liron Pantanowitz, Douglas Hartman and Jeffrey Fine Discuss the Future of Digital Pathology

Douglas J. Hartman, M.D., Assistant Professor, Pathology, University of Pittsburgh Medical Center
Jeffrey Fine, M.D., Assistant Professor, Pathology, University of Pittsburgh School of Medicine
Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center

The University of Pittsburgh Medical Center’s Liron Pantanowitz, Douglas Hartman, and Jeffrey Fine discuss the future of digital pathology, what they are most looking forward to at CHI’s Digital Pathology conference, changes in the field, highlights from their presentations in February, as well as how UPMC has become a leading organization in digital pathology.

Register Now
March 26-27, 2024

AI in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 27-28, 2024

AI in Diagnostics

Diagnostics Market Access

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Single-Cell Multiomics